Jodi Rintelman is a part-time pharmacist and an aspiring medical writer with a personal interest in mental health. She spent the last 11 years in community and long-term care pharmacy, and she did her pharmacy internship in neurology and psychiatry at the University of Wisconsin Hospital and Clinics. She began her career in journalism and has now returned to writing, completing a medical writing and editing certificate program through the University of Chicago and interning with Health Literacy Media in St. Louis. She is excited to combine her pharmacy experience with her love for writing to help make health information more accessible to those who need it most.
Jodi Rintelman writes her debut elf blog on the first randomised controlled trial on the efficacy and safety of intranasal esketamine as an adjunctive treatment to antidepressants for treatment-resistant depression.[read the full story...]